Cell study: loss of NEFH in skin neurons drives fibroblast aging and collagen loss in mice
Wang et al. found that glutamatergic neurons innervating mouse skin sustain fibroblasts and collagen; the age-related decline of this signaling drives skin aging.

A study by Wang et al. published in Cell (doi.org) reports that skin-innervating glutamatergic neurons sustain dermal fibroblast function and collagen homeostasis in mice. According to the authors, the age-related decline of this pathway drives fibroblast senescence and skin aging biomedcentral.com
doi.orgbiomedcentral.comOpen source ↗. The work is preclinical: the experiments were done in mice, supplemented by data from aged human and mouse skin.
Neurons and fibroblast senescence
With age, skin loses collagen, repairs wounds less well and becomes more susceptible to infection and malignancy. Senescent dermal fibroblasts accumulate in aged skin. They express p16, acquire a senescence-associated secretory phenotype and progressively lose their capacity to produce collagen. The upstream regulation of this process has remained largely unknown.
The authors used several cutaneous denervation models. Denervation increased p16 expression and accelerated collagen loss. The authors stress that these phenotypes are a proxy for, not equivalent to, full physiological skin aging.
In public transcriptomic datasets, Nefh was among the most strongly downregulated genes in aged human skin. NEFH protein was reduced in both aged human and mouse skin, correlating negatively with age and positively with collagen abundance. The human data are associative. Single-cell transcriptomics localized NEFH mainly to VGLUT2-positive glutamatergic neurons, whose fibers contact fibroblasts biomedcentral.com
doi.orgbiomedcentral.comOpen source ↗.
The NEFH–CDK5–VGLUT2 pathway
Deleting Nefh in skin-innervating neurons produced collagen depletion, p16 upregulation and fibroblast senescence, shown by SA-β-gal staining. VGLUT2 expression fell markedly. Tissue glutamate was reduced in aged human and mouse skin, and after denervation or Nefh downregulation. This is not a direct measure of neuronal release, so the data support, but do not prove, impaired glutamate release.
Proteomic and co-immunoprecipitation analyses identified CDK5 as a NEFH-interacting protein that also interacts with VGLUT2. NEFH deficiency reduced neuronal CDK5 and VGLUT2 and impaired glutamate release. Overexpression of Cdk5 restored VGLUT2 levels and glutamate production. Whether NEFH controls VGLUT2 directly or through CDK5-dependent intermediates remains unresolved.
Intracutaneous glutamate injection into Nefh fl/fl; Vglut2 Cre mice, which carry a global rather than neuron-restricted Nefh deletion, rescued the collagen loss and fibroblast senescence. Glutamate supplementation also ameliorated senescence and skin aging phenotypes in a way that depends on SLC1A3 on fibroblasts. The authors conclude that a neuronal NEFH–CDK5–VGLUT2 to glutamate to fibroblast SLC1A3 pathway underlies neuromodulation of skin aging, and suggest that targeting neuronal glutamate release or restoring neuron–fibroblast crosstalk could delay skin aging biomedcentral.com
doi.orgbiomedcentral.comOpen source ↗.



